TREMSUCS-TCGA: A Workflow for Identifying Cancer Treatment Biomarkers
Author Information
Author(s): Balogh Gabor, Jorge Natasha, Dupain Célia, Kamal Maud, Servant Nicolas, Le Tourneau Christophe, Stadler Peter F., Bernhart Stephan H.
Primary Institution: Leipzig University
Hypothesis
Can an automated workflow effectively identify biomarkers for treatment success using TCGA data?
Conclusion
The TREMSUCS-TCGA workflow successfully identifies potential biomarkers for treatment success in various cancer types.
Supporting Evidence
- The workflow is flexible and can analyze various cancer types and treatments.
- Results are presented in a comprehensive report that includes statistical analyses.
- Biomarkers identified are discussed in relation to existing literature.
Takeaway
This study created a computer program that helps doctors find important markers in cancer data to see if treatments are working.
Methodology
The workflow analyzes TCGA data by preprocessing, differential analysis, and post-processing to identify biomarkers linked to treatment success.
Potential Biases
Potential biases may arise from the retrospective nature of the study and the selection of treatment data.
Limitations
The analysis is limited by the availability of treatment data and may not account for all modern treatments.
Participant Demographics
The study included patients with squamous cell carcinomas of the head and neck, cervix, and lung, treated with various chemotherapy regimens.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website